Focal adhesion kinase (FAK) is a non‐receptor tyrosine kinase over‐expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FAK and FAK inhibitors are of great interest for both pharmaceutical companies and academia. This review is focused on compounds able to block FAK with different potencies and with different mechanisms of action, that have appeared in the literature since 2017. Furthermore, new emerging PROTAC molecules have appeared in the literature. This summary could improve knowledge of new FAK inhibitors and provide information for future investigations, in particular, from a medicinal chemistry point of view.
The Development of FAK Inhibitors: A Five-Year Update
Spallarossa, Andrea;Tasso, Bruno;Russo, Eleonora;Villa, Carla;Brullo, Chiara
2022-01-01
Abstract
Focal adhesion kinase (FAK) is a non‐receptor tyrosine kinase over‐expressed in different solid cancers. In recent years, FAK has been recognized as a new target for the development of antitumor agents, useful to contrast tumor development and metastasis formation. To date, studies on the role of FAK and FAK inhibitors are of great interest for both pharmaceutical companies and academia. This review is focused on compounds able to block FAK with different potencies and with different mechanisms of action, that have appeared in the literature since 2017. Furthermore, new emerging PROTAC molecules have appeared in the literature. This summary could improve knowledge of new FAK inhibitors and provide information for future investigations, in particular, from a medicinal chemistry point of view.File | Dimensione | Formato | |
---|---|---|---|
spallarossa_published.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Documento in Post-print
Dimensione
969.51 kB
Formato
Adobe PDF
|
969.51 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.